pEFS in Ph⁺ ALL patients according to postinduction treatment: allogeneic BMT (any type) in CR1/PR compared with chemotherapy alone. The difference between the groups is not significant (P = .47; Mantel-Byar test). “/” indicates the last patient in CR1 entering the trial.